IM to Oral Haloperidol Dose Conversion
A 5 mg intramuscular dose of short-acting haloperidol is approximately equivalent to 10 mg oral haloperidol, using a 1:2 ratio (IM:oral).
Conversion Rationale
The conversion from IM to oral haloperidol is based on bioavailability differences between routes of administration:
- Oral haloperidol has approximately 60% bioavailability due to first-pass hepatic metabolism, while IM administration bypasses this effect 1
- The standard conversion ratio is 1:2 (IM:oral), meaning 5 mg IM haloperidol requires approximately 10 mg oral haloperidol to achieve similar plasma concentrations 1
- Studies examining steady-state plasma concentrations demonstrate that IM haloperidol produces lower peak and mean plasma levels than equivalent oral doses, supporting the need for higher oral dosing 1
Clinical Context from Guidelines
While the provided guidelines focus primarily on acute agitation management rather than direct dose conversions, they offer relevant context:
- Standard IM haloperidol dosing for acute agitation ranges from 2.5-10 mg every 4-6 hours as needed 2
- Oral haloperidol 5 mg combined with lorazepam 2 mg was compared to IM administration in agitation studies, demonstrating comparable efficacy 2
- For maintenance therapy after acute stabilization, the ratio of long-acting IM decanoate to daily oral doses averaged 14.1:1.0 (range 9.4-15.0:1.0), though this applies to depot formulations rather than short-acting IM 1
Practical Application
For converting a patient from 5 mg IM short-acting haloperidol to oral:
- Start with 10 mg oral haloperidol as the equivalent dose 1
- Monitor clinical response closely during the first 24-48 hours, as oral absorption may vary
- Consider that oral haloperidol reaches peak plasma levels in 2-6 hours, compared to 20-40 minutes for IM administration 1
- Dose adjustments should be based on clinical efficacy and tolerability, particularly monitoring for extrapyramidal symptoms which increase with doses above 7.5 mg/day 3
Important Caveats
- This conversion applies to short-acting IM haloperidol only, not haloperidol decanoate (long-acting depot), which has entirely different pharmacokinetics 4, 1
- In elderly or debilitated patients, lower doses are appropriate regardless of route, with initial oral doses of 0.5-2 mg recommended 5
- The 1:2 ratio is an approximation; individual patient factors including age, hepatic function, and concurrent medications may alter the actual dose needed 1
- Recent consensus guidelines suggest standard dosing ranges of 5-20 mg/day oral haloperidol for maintenance treatment of schizophrenia, with target ranges individualized based on response 6